As a result, GLP1 coverage can remain financially challenging even as its clinical value becomes more evident and the right strategy can vary widely by employer
Modifiable risk factors, such as diet and exercise, are important targets for intervention in the management of T2DM [2, 3]
Read the full review Nutrition & Metabolic Deficiencies and metabolic drivers of cognitive symptoms
Semaglutide, a GLP-1 receptor agonist, has transformed weight management for millions of people, but emerging patient reports and clinical observations suggest mood changesincluding anxietymay occur during treatment
With rising consumer spending on nutraceuticals, functional foods, and preventive healthcare, the Collagen Peptides Market is set for strong growth from 2024 to 2033, fueled by both innovation and demand across global regions